Practical: AI & Business News podkast

Eli Lilly Shocks Wall Street: Global Demand for Weight-Loss Drugs Sends Forecast Soaring!

0:00
7:38
Do tyłu o 15 sekund
Do przodu o 15 sekund

Eli Lilly has raised its full-year forecast after unprecedented international demand for its hit weight-loss and diabetes drugs, Mounjaro and Zepbound. The pharmaceutical giant’s booming sales and rapid global expansion signal a new era for obesity treatment worldwide.

Więcej odcinków z kanału "Practical: AI & Business News"